THE FACTORY HKA USA, INC. – Trademark Portfolio
Entity Type: 03
THE FACTORY HKA USA, INC. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 6 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include MEFIC, OKIMA, SCYLLA, DAMEFIC, and GANESHA. The owner is based in Hollywood, FL.
Unit 702
2450 Hollywood Blvd.
Hollywood, FL 33020
Showing of trademarks Trademarks
Trademark Classifications
THE FACTORY HKA USA, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does THE FACTORY HKA USA, INC. have?
THE FACTORY HKA USA, INC. has 7 U.S. trademarks filed with the USPTO. Of these, 5 registered, 1 abandoned, 1 cancelled.
What trademark classes does THE FACTORY HKA USA, INC. file in?
THE FACTORY HKA USA, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 35 (Advertising & Business). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are THE FACTORY HKA USA, INC.'s most well-known trademarks?
THE FACTORY HKA USA, INC.'s registered trademark portfolio includes well-known marks such as MEFIC, OKIMA, SCYLLA, DAMEFIC, and GANESHA. These are among 5 currently registered trademarks in the portfolio.
What is THE FACTORY HKA USA, INC.'s trademark registration success rate?
THE FACTORY HKA USA, INC. has a 71% trademark registration rate, with 5 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.